Early Day Notes: Symantec Corporation (NASDAQ:SYMC), Gilead Sciences (NASDAQ:GILD), Peabody Energy Corporation (NYSE:BTU), BioScrip (NASDAQ:BIOS)

On 19 January, KeyCorp. (NYSE:KEY) shares moved down -1.56% and was closed at $11.33. KEY EPS growth in last 5 year was 19.70%. KeyCorp. (NYSE:KEY) year to date (YTD) performance is -14.10%.

KeyCorp. (NYSE:KEY) will announce fourth quarter 2015 earnings on Thursday, January 21, 2016, before the market opens. A conference call will be held at 10:00 a.m. ET to review financial results, strategy and outlook.

Symantec Corporation (NASDAQ:SYMC) shares moved down -3.55% in last trading session and ended the day at $19.03. SYMC Gross Margin is 82.40% and its has a return on assets of 5.20%. Symantec Corporation (NASDAQ:SYMC) quarterly performance is -7.42%.

Symantec Corporation (NASDAQ:SYMC) and The Carlyle Group (NASDAQ: CG) announced that they expect to close Carlyle’s acquisition of Veritas on January 29, 2016, subject to the satisfaction of customary closing conditions. The closing was previously expected to take place on January 1, 2016.

Gilead Sciences Inc. (NASDAQ:GILD) caters to the Healthcare space. It has a net profit margin of 53.80% and weekly performance is -6.84%. On the last day of trading company shares ended up at $89.90. Gilead Sciences Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is -36.07%.

On 5 January, Gilead Sciences Inc. (NASDAQ:GILD) announced that two Phase 3 clinical trials (Studies 108 and 110) evaluating investigational use of once-daily tenofovir alafenamide (TAF) 25 mg in treatment-naïve and treatment-experienced adults with HBeAg-negative and HBeAg-positive chronic hepatitis B virus (HBV) infection met their primary objectives.

Peabody Energy Corporation (NYSE:BTU) shares moved down -11.70% in last trading session and ended the day at $3.47. BTU Gross Margin is 13.40% and its has a return on assets of -16.40%. Peabody Energy Corporation (NYSE:BTU) quarterly performance is -84.71%.

Peabody Energy Corporation (NYSE:BTU) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Tuesday, Marketbeat reports.

BioScrip, Inc. (NASDAQ:BIOS) caters to the Healthcare space. It has a net profit margin of -37.70% and weekly performance is 15.27%. On the last day of trading company shares ended up at $1.51. BioScrip, Inc. (NASDAQ:BIOS) distance from 50-day simple moving average (SMA50) is -5.08%.

BioScrip, Inc. (NASDAQ:BIOS) provided an update on the Company’s progress implementing its Financial Improvement Plan to enhance shareholder value, improve financial flexibility and position BioScrip for success in 2016. As previously announced, the Company expects the Financial Improvement Plan to realize $35 million – $40 million in annualized net cost savings.